Desoxypipradrol, acts as a norepinephrine-dopamine reuptake inhibitor (NDRI) designed by Ciba from the fifties. Desoxypipradrol is closely linked on a structural stage for the compounds methylphenidate and pipradrol, all three of which share a similar pharmacological motion.The authors are grateful to Damicom srl, a little company from Rome (Italy)